| |
Bradykinin (1-3)  |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP11130-5 mg
| 5 mg | $ 23.75 | MSDS: 20080922220210 (PDF)
References:
- Fischer LG, et al. Bradykinin-induced pulmonary vasoconstriction is time and inducible nitric oxide synthase dependent in a peritonitis sepsis model. Anesth. Analg. Sep 2004; 99(3): 864-871.
- Cruden NL, et al. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure. Arterioscler. Thromb. Vasc. Biol. Apr 2005;25(4): 772-777.
- Lucchesi PA, et al. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation. Dec 2004;110(23): 3587-3593.
|
|---|
| Full Name | |
Sequence
(one-letter code) |
RPP | Sequence
(three-letter code) | {ARG}{PRO}{PRO} |
|---|
| Description | Bradykinin (1-3) is a fragment of Bradykinin. Bradykinin is an activates pain receptors. Bradykinin induces smooth muscle contraction; activates Ca2+-dependent nitric oxide synthetase. Bradykinin can also increase capillary permeability. Bradykinin is a potent stimulator of nitric oxide formation by vascular endothelium. Bradykinin also stimulates prostacyclin formation. |
|---|
| Formula | C16H28N6O4 |
|---|
| M.W. | 368.4 |
|---|
| Purity | > 95% |
|---|
| Storage | Store at -20°C. |
|
